I'm not talking about PVCT and Pv-10. So you do not have to persuade me. I'm more interested in what VBIV will do with their vaccine + check point inhibitors. I think most have given up on PVCT ever delivery on anything. First the CEo would not steal if they were close to something.
The longs here are getting a good lesson in what to watch out for.
Good point, but would you want the side effects of chemo or a check point inhibitor? Here is a recent article about what you are referencing.
Checkpoint inhibitors can produce immune-related side effects in any organ or system of the body: the skin, gastrointestinal tract, endocrine glands, liver, nervous system, and pulmonary system. They can cause inflammatory conditions such as colitis, hypophysitis, nephritis, and uveitis—anything that ends in -itis. The most common side effects, however, are fatigue, rash, mild nausea, and decreased appetite, all of which are relatively easy for the patient to tolerate and the physician to treat. We also commonly see elevated or decreased thyroid hormone levels, which we are able to treat.
Approximately 70% of patients receiving a checkpoint inhibitor experience some type of side effect. Only 10% of patients experience a grade 3 or 4 side effect, however. Those percentages are pretty consistent across all of the checkpoint inhibitors. It is important to remember that clinical trials have shown that checkpoint inhibitors produce less toxicity than does single-agent chemotherapy. Side effects that cause death or require discontinuation of the checkpoint inhibitor are rare.
Is this vorlon or a mock id?
Having a drug that wakes up the immune system is a good idea, having one that recruits the immune cells to the tumor is better, having a drug that can do it all by triggering the whole cascade of multiple paths is best.
I like VBIV in this field. Read their latest press releases on what they are discovering. Looks like my prediction of .25 here is on course. Sorry that is happening to honest investors, but the clowns like JZ and edgars, you needed a wake up call. Maybe next time you see the red flags and understand that raising capital is what biotechs are about. Some do it with deception.
VBIV be aware they are merging with SVACF, they will do a RS after this. So take a look and keep it on your radar.
Would you as CEO steal from your company if you were actually close to something real? When the dust clears here, the longs will sit back and most of this will finally be clear to them. BTD was smoke and mirrors, ph3 trial dragging out 4 years. PD10 sitting on the shelf for 6 years.
White collar crime is on the surge. Thanks to a few here, they get away with it longer then they should.
Some of this is funny, some of it ridiculous. I understand that the pumpers did anything they could to defame and this is payback. I never understood the mocking id's. What happen to just being true to yourself and letting your views play out. I get more satisfaction that I warned here, that I pointed out who the multiple id's were and in the end, i didn't lose money and maybe convinced honest investors to watch out for this one.
Everyone needs to grow up. Inventing 10 id's is for children and this board had a lot of children running around on it.
Don't leave out Edgars id. He ran off after posting this would go to $6 and then to .50. He erased it, but Hillary learned that nothing stays erased.
The pumpers were all here to help move the dilution. BTW, remember I called that this would hit .25. JZ and others here owe concerned investors an apology. You followed us around on other boards and called us names, well now you are finding out, that we actual knew what we were pointing out.
I am not surprised by the recent news. Just imagine what they would have stolen, if AF had not taken the air out of this. The story sounded believable and that is how they work it. Hopefully this is a lesson well learned.
This is a good lesson investing in bio's and what to watch out for. You never know if your instincts are right, until these moments show it clearly. Hopefully the little boys here...grow up finally.
VBI shareholders will get 20.80836 shares for each one they own. So when the dust settles there will be 1.4B shares in Svacf. The story I'm hearing is they will then do a RS. As for pipe dream all biotechs are a pipe dream. They have to raise capital and get their drugs into trials. Svacf has a lead drug that is approved in 15 countries, but not USA. VBI has 3 drugs they are working on with none in trials.
VBI has an interesting way to allow to transport vaccines without cold storage. They will need capital or they will need to partner something. I look at this as a POC investment, where maybe the big boys take it over.
Good management in VBI, poor management in Svacf. Lucky the VBI will be taking over once the deal is done. For info look at VBI website, they are presenting data this week. Has strong ties to GSK and I feel one day, that's where this will end up. I own a ton of this, once this deal gets done.
I look for them to advance the hep B and partner something. But when is the difficult part to guess. You have to do your own DD on buying more. They will need more money. The RS could be anywhere from 1 for 25 to 1 for 50. It all depends on if they have some news.